Expression of the oestrogen responsive protein pS2 in human breast cancer

Por favor, use este identificador para citar o enlazar este ítem: http://hdl.handle.net/10201/19170

RefMan EndNote BibTex RefWorks Excel CSV PDF Mendeley

Registro completo de metadatos

Campo DC	Valor	Lengua/Idioma
dc.contributor.author	Balleine, R.L.	es
dc.contributor.author	Clarke, C.L.	es
dc.date.accessioned	2011-02-22T11:08:25Z	-
dc.date.available	2011-02-22T11:08:25Z	-
dc.date.issued	1999	-
dc.identifier.issn	0213-3911	es
dc.identifier.uri	http://hdl.handle.net/10201/19170	-
dc.description.abstract	The trefoil peptide pS2 was discovered in a breast cancer cell line as a result of its oestrogen responsive character. The expression of pS2 in breast tumours in vivo is also likely to be an oestrogenic effect and as such, the presence of pS2 in oestrogen receptor positive breast cancer is evidence of an intact oestrogen response pathway and an indicator of putative hormone responsiveness. Consistent with this, clinical studies of breast cancer have revealed a correlation between pS2 expression and favourable tumour characteristics as well as response to endocrine therapy.	es
dc.format	application/pdf	es
dc.format.extent	8	es
dc.language	eng	es
dc.publisher	Murcia : F. Hernández	es
dc.relation.ispartof	Histology and histopathology	es
dc.rights	info:eu-repo/semantics/openAccess	es
dc.subject	Breast neoplasms	es
dc.subject.other	CDU::6 - Ciencias aplicadas::61 - Medicina	es
dc.title	Expression of the oestrogen responsive protein pS2 in human breast cancer	es
dc.type	info:eu-repo/semantics/article	es
Aparece en las colecciones:	Vol.14, nº 2 (1999)

Ficheros en este ítem:

Fichero	Descripción	Tamaño	Formato
Expression of the oestrogen responsive protein pS2 in human breast cancer.pdf		5,07 MB	Adobe PDF	Visualizar/Abrir